Skip to main content

Advertisement

SpringerLink
Log in

Understanding thrombotic microangiopathies in children

  • Understanding the Disease
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371:654–666

    Article  PubMed  CAS  Google Scholar 

  2. George JN, Al-Nouri ZL (2012) Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes. Am Soc Hematol Educ Progr 2012:604–609

    Google Scholar 

  3. Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589–600

    Article  PubMed  CAS  Google Scholar 

  4. Scully M, Cataland S, Coppo P et al (2017) Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost 15:312–322

    Article  PubMed  CAS  Google Scholar 

  5. Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361:1676–1687

    Article  PubMed  CAS  Google Scholar 

  6. Fakhouri F, Zuber J, Frémeaux-Bacchi V et al (2017) Haemolytic uraemic syndrome. Lancet 390:681–696

    Article  PubMed  Google Scholar 

  7. Grangé S, Bekri S, Artaud-Macari E et al (2015) Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency. Lancet 386:1011–1012

    Article  PubMed  Google Scholar 

  8. Zuber J, Fakhouri F, Roumenina LT et al (2012) Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 8:643–657

    Article  PubMed  CAS  Google Scholar 

  9. Licht C, Ardissino G, Ariceta G et al (2015) The global aHUS registry: methodology and initial patient characteristics. BMC Nephrol 16:207

    Article  PubMed  PubMed Central  Google Scholar 

  10. Noris M, Caprioli J, Bresin E et al (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844–1859

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Joly BS, Coppo P, Veyradier A (2017) Thrombotic thrombocytopenic purpura. Blood 129:2836–2846

    Article  PubMed  CAS  Google Scholar 

  12. Saha M, McDaniel JK, Zheng XL (2017) Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapies. J Thromb Haemost 15:1889–1900

    Article  PubMed  CAS  Google Scholar 

  13. Furlan M, Robles R, Galbusera M et al (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578–1584

    Article  PubMed  CAS  Google Scholar 

  14. Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585–1594

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Levy GG, Nichols WC, Lian EC et al (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488–494

    Article  PubMed  CAS  Google Scholar 

  16. Joly BS, Stepanian A, Leblanc T et al (2016) Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy. Lancet Haematol 3:e537–e546

    Article  PubMed  Google Scholar 

  17. Reese JA, Muthurajah DS, Kremer Hovinga JA et al (2013) Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer 60:1676–1682

    Article  PubMed  Google Scholar 

  18. Joly BS, Vanhoorelbeke K, Veyradier A (2017) Understanding therapeutic targets in thrombotic thrombocytopenic purpura. Intensive Care Med. https://doi.org/10.1007/s00134-016-4662-3

    Article  PubMed  Google Scholar 

  19. Scully M, Knöbl P, Kentouche K et al (2017) Recombinant human ADAMTS-13: first in human study evaluating pharmacokinetics, safety and tolerability in cTTP patients. Blood 130:2055–2063

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’hématologie biologique and EA3518-Institut universitaire d’hématologie, Groupe Hospitalier Saint Louis-Lariboisière Assistance Publique – Hôpitaux de Paris, Université Paris Diderot, Paris, France

    Bérangère S. Joly & Agnès Veyradier

  2. French National Reference Centre for Thrombotic MicroAngiopathies, Assistance Publique – Hôpitaux de Paris, Paris, France

    Bérangère S. Joly & Agnès Veyradier

  3. Division of Laboratory Medicine, Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, 35249, USA

    X. Long Zheng

Authors
  1. Bérangère S. Joly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X. Long Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Agnès Veyradier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Agnès Veyradier.

Ethics declarations

Conflicts of interest

BSJ is recipient of the MaRIH research grant Alexion 2016; AV is a member of the French Advisory board on Caplacizumab (Ablynx); XLZ is a consultant for Ablynx and a member of the speakers’ bureau for Alexion.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Joly, B.S., Zheng, X.L. & Veyradier, A. Understanding thrombotic microangiopathies in children. Intensive Care Med 44, 1536–1538 (2018). https://doi.org/10.1007/s00134-018-5059-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-018-5059-2

Keywords

Search

Navigation